Omega Therapeutics Inc is a pioneering biotechnology company dedicated to developing innovative epigenetic mRNA medicines targeting a wide array of diseases. Utilizing its proprietary Omega Epigenetics Engine, the company is poised to unlock the potential of the epigenome, driving advancements in genetics and personalized medicine. With a promising pipeline of therapeutics spanning multiple developmental stages, Omega Therapeutics stands at the forefront of precision healthcare, strategically addressing some of the most significant unmet medical needs. Its unwavering commitment to scientific excellence and strategic collaborations positions it as a key player in reshaping treatment paradigms for patients globally. Show more

20 ACORN PARK DRIVE, CAMBRIDGE, MA, UNITED STATES, 02140, USA

BIOTECHNOLOGY
HEALTHCARE

Market Cap

7.895M

52 Wk Range

$0.00 - $0.00

Previous Close

$0.14

Open

$0.14

Volume

N/A

Day Range

$0.14 - $0.14

Enterprise Value

0.00

Cash

30.38M

Avg Qtr Burn

-14.02M

Insider Ownership

1.67%

Institutional Own.

87.75%

Qtr Updated

09/30/24


Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.